首页> 外文会议>Optical methods for tumor treatment and detection: mechanisms and techniques in photodynamic therapy XXIV >Block copolymers encapsulated poly (aryl benzyl ether) dendrimer silicon (Ⅳ) phthalocyanine for in vivo and in vitro photodynamic efficacy of choroidal neovascularization
【24h】

Block copolymers encapsulated poly (aryl benzyl ether) dendrimer silicon (Ⅳ) phthalocyanine for in vivo and in vitro photodynamic efficacy of choroidal neovascularization

机译:嵌段共聚物包封的聚(芳基苄基醚)树枝状硅(Ⅳ)酞菁对脉络膜新生血管的体内和体外光动力功效

获取原文
获取原文并翻译 | 示例

摘要

A novel series of poly (aryl benzyl ether) dendrimer silicon phthalocyanines loaded block copolymers ethoxypoly(ethylene glycol)-poly (lactic-co-glycolic acid) (MPEG-PLGA)were formed. The time-dependent intracellular uptake of nanoparticles in HUVECs cells increased as they were incorporated into nanoparticles. With its highly effective selective accumulation on choroidal neovascularization(CNV). This treatment resulted in a efficacious choroidal neovascularization (CNV) occlusion with minimal unfavorable phototoxicity.
机译:形成了一系列新型的聚(芳苄基醚)树枝状硅酞菁负载嵌段共聚物乙氧基聚(乙二醇)-聚(乳酸-乙醇酸共聚物)(MPEG-PLGA)。随着时间的推移,HUVECs细胞中纳米颗粒的细胞内摄取随着它们被掺入纳米颗粒而增加。以其对脉络膜新血管形成(CNV)的高效选择性积累。这种治疗导致有效的脉络膜新血管形成(CNV)阻塞,且光毒性最小。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号